UAS promotes synbiotic blends

By staff reporter

- Last updated on GMT

Related tags Probiotic

Minnesota-based probiotics specialist UAS laboratories is promoting four specialist blends utilizing a range of its proprietary probiotic strains and prebiotic fructooligosaccharides (FOS).

The company’s founder and president Dr S.K. Dash said the formulas were targeted at different conditions and were backed by many studies both published and unpublished.

The four blends are:

  • L. acidophilus DDS-1, Bifidobacterium longum plus FOS (5 billion CFU/gram)
  • L. acidophilus DDS-1, B. lactis plus FOS (5 billion CFU/gram)
  • L. acidophilus DDS-1, B. longum, B. lactis, B. bifidum plus FOS (10 billion CFU/gram)
  • Lactobacillus acidophilus DD-1 plus FOS (5 billion CFU/gram)

The company noted a recent clinical trial demonstrating the potential of a blend containing DDS-1, B. longum, B. lactis and B. bifidum ​to aid irritable bowel syndrome (IBS). The research was being prepared for clinical publication, Dr Dash said.

UAS Labs said its blends were room temperature stable with seven percent loss of potency in one year.

In its B2B literature, the company notes health benefits of its strains including:

  • Human isolates that adapt well to the human body
  • Acid and bile resistance that make it well-suited for intestinal survival
  • Ability to promote digestive health
  • Creates an unfavorable environment for pathogens
  • Maintains natural immune defenses
  • Contributes to good balance of intestinal flora

Related news

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

New postbiotic for gut & skin health benefits

New postbiotic for gut & skin health benefits

Content provided by Kerry ProActive Health | 14-May-2024 | Product Presentation

Plenibiotic™ (Lactobacillus casei subsp. casei 327) is a rice-derived postbiotic providing a holistic approach to digestive and skin health. It offers...

Related suppliers

Follow us


View more